A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT05533775 · RECRUITING
Trial details
- NCT number
- NCT05533775
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-16
- Primary completion
- 2029-11-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.